Homelessness as a Structural Barrier to Effective Antiretroviral Therapy Among HIV-Seropositive Illicit Drug Users in a Canadian Setting
Publication: AIDS Patient Care and STDs
Volume 26, Issue Number 1
Abstract
Despite the advent of effective antiretroviral therapy (ART), HIV-seropositive injection drug users (IDU) continue to suffer from elevated levels of morbidity and mortality. Evidence is needed to identify social- and structural-level barriers to effective ART. We investigated the impact of homelessness on plasma HIV RNA response among illicit drug users initiating ART in a setting with free and universal access to HIV care. We accessed data from a long-running prospective cohort of community-recruited IDU linked to comprehensive HIV clinical monitoring and ART dispensation records. Using Cox proportional hazards with recurrent events modeling, we estimated the independent effect of homelessness on time to plasma HIV viral load suppression. Between May 1996 and September 2009, 247 antiretroviral naïve individuals initiated ART and contributed 1755 person–years of follow-up. Among these individuals, the incidence density of plasma HIV RNA suppression less than 500 copies/mm3 was 56.7 (95% confidence interval [CI]: 46.9–66.0) per 100 person–years. In unadjusted analyses, homelessness was strongly associated with lower rates suppression (hazard ratio=0.56, 95% CI: 0.40–0.78, p=0.001), however, after adjustment for adherence this association was no longer significant (adjusted hazard ratio=0.79, 95% CI: 0.56–1.11, p=0.177). Homelessness poses a significant structural barrier to effective HIV treatment. However, since this relationship appears to be mediated by lower levels of ART adherence, interventions to improve adherence among members of this vulnerable population are needed.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Hogg RSHeath KVYip B et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapyJAMA1998279450-454. 1. Hogg RS, Heath KV, Yip B, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 1998;279:450–454.
2.
Porter KBabiker ABhaskaran KDarbyshire JPezzotti PWalker AS. Determinants of survival following HIV-1 seroconversion after the introduction of HAARTLancet20033621267-1274. 2. Porter K, Babiker A, Bhaskaran K, Darbyshire J, Pezzotti P, Walker AS. Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet 2003;362:1267–1274.
3.
Shannon KBright VDuddy JTyndall MW. Access and utilization of HIV treatment and services among women sex workers in Vancouver's downtown eastsideJ Urban Health200582488-497. 3. Shannon K, Bright V, Duddy J, Tyndall MW. Access and utilization of HIV treatment and services among women sex workers in Vancouver's downtown eastside. J Urban Health 2005;82:488–497.
4.
Stein MDRich JDMaksad J et al. Adherence to antiretroviral therapy among HIV-infected methadone patients: Effect of ongoing illicit drug useAm J Drug Alcohol Abuse200026195-205. 4. Stein MD, Rich JD, Maksad J, et al. Adherence to antiretroviral therapy among HIV-infected methadone patients: Effect of ongoing illicit drug use. Am J Drug Alcohol Abuse 2000;26:195–205.
5.
Krüsi AWood EMontaner JKerr T. Social and structural determinants of HAART access and adherence among injection drug usersInt J Drug Pol2010214-9. 5. Krüsi A, Wood E, Montaner J, Kerr T. Social and structural determinants of HAART access and adherence among injection drug users. Int J Drug Pol 2010;21:4–9.
6.
Allen DMLehman JSGreen TALindegren MLOnorato IMForrester W. HIV infection among homeless adults and runaway youth, United States, 1989–1992. Field Services BranchAIDS199481593-1598. 6. Allen DM, Lehman JS, Green TA, Lindegren ML, Onorato IM, Forrester W. HIV infection among homeless adults and runaway youth, United States, 1989–1992. Field Services Branch. AIDS 1994;8:1593–1598.
7.
Robertson MJClark RACharlebois ED et al. HIV seroprevalence among homeless and marginally housed adults in San FranciscoAm J Public Health2004941207-1217. 7. Robertson MJ, Clark RA, Charlebois ED, et al. HIV seroprevalence among homeless and marginally housed adults in San Francisco. Am J Public Health 2004;94:1207–1217.
8.
Torres RAMani SAltholz JBrickner PW. Human immunodeficiency virus infection among homeless men in a New York City shelter. Association with Mycobacterium tuberculosis infectionArch Intern Med19901502030-2036. 8. Torres RA, Mani S, Altholz J, Brickner PW. Human immunodeficiency virus infection among homeless men in a New York City shelter. Association with Mycobacterium tuberculosis infection. Arch Intern Med 1990;150:2030–2036.
9.
Smith MYRapkin BDWinkel GSpringer CChhabra RFeldman IS. Housing status and health care service utilization among low-income persons with HIV/AIDSJ Gen Intern Med200015731-738. 9. Smith MY, Rapkin BD, Winkel G, Springer C, Chhabra R, Feldman IS. Housing status and health care service utilization among low-income persons with HIV/AIDS. J Gen Intern Med 2000;15:731–738.
10.
Fichter MMQuadflieg N. Prevalence of mental illness in homeless men in Munich, Germany: Results from a representative sampleActa Psychiatr Scand200110394-104. 10. Fichter MM, Quadflieg N. Prevalence of mental illness in homeless men in Munich, Germany: Results from a representative sample. Acta Psychiatr Scand 2001;103:94–104.
11.
Das-Douglas MColfax GMoss ARBangsberg DRHahn JA. Tripling of methamphetamine/amphetamine use among homeless and marginally housed persons, 1996–2003J Urban Health200885239-249. 11. Das-Douglas M, Colfax G, Moss AR, Bangsberg DR, Hahn JA. Tripling of methamphetamine/amphetamine use among homeless and marginally housed persons, 1996–2003. J Urban Health 2008;85:239–249.
12.
Kushel MBHahn JAEvans JLBangsberg DRMoss AR. Revolving doors: Imprisonment among the homeless and marginally housed populationAm J Public Health2005951747-1752. 12. Kushel MB, Hahn JA, Evans JL, Bangsberg DR, Moss AR. Revolving doors: Imprisonment among the homeless and marginally housed population. Am J Public Health 2005;95:1747–1752.
13.
Heslin KCRobinson PLBaker RSGelberg L. Community characteristics and violence against homeless women in Los Angeles CountyJ Health Care Poor Underserved200718203-218. 13. Heslin KC, Robinson PL, Baker RS, Gelberg L. Community characteristics and violence against homeless women in Los Angeles County. J Health Care Poor Underserved 2007;18:203–218.
14.
Buchér JBThomas KMGuzman DRiley EDela Cruz NBangsberg DR. Community-based rapid HIV testing in homeless and marginally housed adults in San FranciscoHIV Med2007828-31. 14. Buchér JB, Thomas KM, Guzman D, Riley E, Dela Cruz N, Bangsberg DR. Community-based rapid HIV testing in homeless and marginally housed adults in San Francisco. HIV Med 2007;8:28–31.
15.
Aidala AALee GAbramson DMMesseri PSiegler A. Housing need, housing assistance, and connection to HIV medical careAIDS Behav2007116 Suppl101-115. 15. Aidala AA, Lee G, Abramson DM, Messeri P, Siegler A. Housing need, housing assistance, and connection to HIV medical care. AIDS Behav 2007;11(6 Suppl):101–115.
16.
Leaver CABargh GDunn JRHwang SW. The effects of housing status on health-related outcomes in people living with HIV: A systematic review of the literatureAIDS Behav2007116 Suppl85-100. 16. Leaver CA, Bargh G, Dunn JR, Hwang SW. The effects of housing status on health-related outcomes in people living with HIV: A systematic review of the literature. AIDS Behav 2007;11(6 Suppl):85–100.
17.
Weiser SDFrongillo EARagland KHogg RSRiley EDBangsberg DR. Food insecurity is associated with incomplete HIV RNA suppression among homeless and marginally housed HIV-infected individuals in San FranciscoJ Gen Intern Med20092414-20. 17. Weiser SD, Frongillo EA, Ragland K, Hogg RS, Riley ED, Bangsberg DR. Food insecurity is associated with incomplete HIV RNA suppression among homeless and marginally housed HIV-infected individuals in San Francisco. J Gen Intern Med 2009;24:14–20.
18.
Galea SVlahov D. Social determinants and the health of drug users: Socioeconomic status, homelessness, and incarcerationPublic Health Rep2002117Suppl 1S135-145. 18. Galea S, Vlahov D. Social determinants and the health of drug users: Socioeconomic status, homelessness, and incarceration. Public Health Rep 2002;117(Suppl 1):S135–145.
19.
Bangsberg DRHecht FMCharlebois ED et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent populationAIDS200014357-366. 19. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000;14:357–366.
20.
Knowlton ARArnsten JHEldred LJ et al. Antiretroviral use among active injection-drug users: The role of patient-provider engagement and structural factorsAIDS Patient Care STDs201024421-428. 20. Knowlton AR, Arnsten JH, Eldred LJ, et al. Antiretroviral use among active injection-drug users: The role of patient-provider engagement and structural factors. AIDS Patient Care STDs 2010;24:421–428.
21.
Lehavot KHuh DWalters KLKing KMAndrasik MPSimoni JM. Buffering effects of general and medication-specific social support on the association between substance use and HIV medication adherenceAIDS Patient Care STDs201125181-189. 21. Lehavot K, Huh D, Walters KL, King KM, Andrasik MP, Simoni JM. Buffering effects of general and medication-specific social support on the association between substance use and HIV medication adherence. AIDS Patient Care STDs 2011;25:181–189.
22.
Moss AHahn JPerry S et al. Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: A prospective studyClin Infect Dis2004391190-1198. 22. Moss A, Hahn J, Perry S, et al. Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: A prospective study. Clin Infect Dis 2004;39:1190–1198.
23.
Weiser SDBangsberg DRKegeles SRagland KKushel MBFrongillo EA. Food insecurity among homeless and marginally housed individuals living with HIV/AIDS in San FranciscoAIDS Behav200913841-848. 23. Weiser SD, Bangsberg DR, Kegeles S, Ragland K, Kushel MB, Frongillo EA. Food insecurity among homeless and marginally housed individuals living with HIV/AIDS in San Francisco. AIDS Behav 2009;13:841–848.
24.
Nolan SMilloy MJZhang R et al. Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian settingAIDS Care(in press). 24. Nolan S, Milloy MJ, Zhang R, et al. Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting. AIDS Care (in press).
25.
Palepu AMilloy MJKerr TZhang RWood E. Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug usersJ Urban Health201188545-555. 25. Palepu A, Milloy MJ, Kerr T, Zhang R, Wood E. Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users. J Urban Health 2011;88:545–555.
26.
Strathdee SAPalepu ACornelisse PG et al. Barriers to use of free antiretroviral therapy in injection drug usersJAMA1998280547-549. 26. Strathdee SA, Palepu A, Cornelisse PG, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA 1998;280:547–549.
27.
Wood EHogg RSBonner S et al. Staging for antiretroviral therapy among HIV-infected drug usersJAMA20042921175-1177. 27. Wood E, Hogg RS, Bonner S, et al. Staging for antiretroviral therapy among HIV-infected drug users. JAMA 2004;292:1175–1177.
28.
Wood EHogg RSLima VD et al. Highly active antiretroviral therapy and survival in HIV-infected injection drug usersJAMA2008300550-554. 28. Wood E, Hogg RS, Lima VD, et al. Highly active antiretroviral therapy and survival in HIV-infected injection drug users. JAMA 2008;300:550–554.
29.
Wood EHogg RSYip BHarrigan PRO'Shaughnessy MVMontaner JS. Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?AIDS200317711-720. 29. Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS. Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy? AIDS 2003;17:711–720.
30.
Wood EHogg RSYip BHarrigan PRO'Shaughnessy MVMontaner JS. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350×10(9) cells/LAnn Intern Med2003139810-816. 30. Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350×10(9) cells/L. Ann Intern Med 2003;139:810–816.
31.
Low-Beer SYip BO'Shaughnessy MVHogg RSMontaner JS. Adherence to triple therapy and viral load responseJ Acquir Immune Defic Syndr200023360-361. 31. Low-Beer S, Yip B, O'Shaughnessy MV, Hogg RS, Montaner JS. Adherence to triple therapy and viral load response. J Acquir Immune Defic Syndr 2000;23:360–361.
32.
Palepu AYip BMiller C et al. Factors associated with the response to antiretroviral therapy among HIV-infected patients with and without a history of injection drug useAIDS200115423-424. 32. Palepu A, Yip B, Miller C, et al. Factors associated with the response to antiretroviral therapy among HIV-infected patients with and without a history of injection drug use. AIDS 2001;15:423–424.
33.
Wood EMontaner JSYip B et al. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug usersCMAJ2003169656-661. 33. Wood E, Montaner JS, Yip B, et al. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. CMAJ 2003;169:656–661.
34.
Maldonado GGreenland S. Simulation study of confounder-selection strategiesAm J Epidemiol1993138923-936. 34. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol 1993;138:923–936.
35.
Rothman KJGreenland SModern EpidemiologyNew YorkLippincott Williams & Wilkins1998. 35. Rothman KJ, Greenland S. Modern Epidemiology. New York: Lippincott Williams & Wilkins, 1998.
36.
Lima VFernandes KRachlis BDruyts EMontaner JHogg R. Migration adversely affects antiretroviral adherence in a population-based cohort of HIV/AIDS patientsSoc Sci Med2009681044-1049. 36. Lima V, Fernandes K, Rachlis B, Druyts E, Montaner J, Hogg R. Migration adversely affects antiretroviral adherence in a population-based cohort of HIV/AIDS patients. Soc Sci Med 2009;68:1044–1049.
37.
Marshall BDKerr TShoveller JAPatterson TLBuxton JAWood E. Homelessness and unstable housing associated with an increased risk of HIV and STI transmission among street-involved youthHealth Place200915753-760. 37. Marshall BD, Kerr T, Shoveller JA, Patterson TL, Buxton JA, Wood E. Homelessness and unstable housing associated with an increased risk of HIV and STI transmission among street-involved youth. Health Place 2009;15:753–760.
38.
Baron RMKenny DA. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerationsJ Pers Soc Psychol1986511173-1182. 38. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173–1182.
39.
Berg KMDemas PAHoward AASchoenbaum EEGourevitch MNArnsten JH. Gender differences in factors associated with adherence to antiretroviral therapyJ Gen Intern Med2004191111-1117. 39. Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med 2004;19:1111–1117.
40.
Carballo ECadarso-Suárez CCarrera I et al. Assessing relationships between health-related quality of life and adherence to antiretroviral therapyQual Life Res200413587-599. 40. Carballo E, Cadarso-Suárez C, Carrera I, et al. Assessing relationships between health-related quality of life and adherence to antiretroviral therapy. Qual Life Res 2004;13:587–599.
41.
Kidder DPWolitski RJCampsmith MLNakamura GV. Health status, health care use, medication use, and medication adherence among homeless and housed people living with HIV/AIDSAm J Public Health2007972238-2245. 41. Kidder DP, Wolitski RJ, Campsmith ML, Nakamura GV. Health status, health care use, medication use, and medication adherence among homeless and housed people living with HIV/AIDS. Am J Public Health 2007;97:2238–2245.
42.
Parruti GManzoli LToro PM et al. Long-term adherence to first-line highly active antiretroviral therapy in a hospital-based cohort: Predictors and impact on virologic response and relapseAIDS Patient Care and STDs20062048-56. 42. Parruti G, Manzoli L, Toro PM, et al. Long-term adherence to first-line highly active antiretroviral therapy in a hospital-based cohort: Predictors and impact on virologic response and relapse. AIDS Patient Care and STDs 2006;20:48–56.
43.
Das-Douglas MRiley EDRagland K et al. Implementation of the Medicare Part D Prescription Drug Benefit is associated with antiretroviral therapy interruptionsAIDS Behav2009131-9. 43. Das-Douglas M, Riley ED, Ragland K, et al. Implementation of the Medicare Part D Prescription Drug Benefit is associated with antiretroviral therapy interruptions. AIDS Behav 2009;13:1–9.
44.
Weiser SDFrongillo EARagland KHogg RSRiley EDBangsberg DR. Food insecurity is associated with incomplete HIV RNA suppression among homeless and marginally housed HIV-infected individuals in San FranciscoJ Gen Intern Med20092414-20. 44. Weiser SD, Frongillo EA, Ragland K, Hogg RS, Riley ED, Bangsberg DR. Food insecurity is associated with incomplete HIV RNA suppression among homeless and marginally housed HIV-infected individuals in San Francisco. J Gen Intern Med 2009;24:14–20.
45.
Bangsberg DTulsky JPHecht FMMoss AR. Protease inhibitors in the homelessJAMA199727863-65. 45. Bangsberg D, Tulsky JP, Hecht FM, Moss AR. Protease inhibitors in the homeless. JAMA 1997;278:63–65.
46.
Scott AEllen JClum GLeonard L. HIV and housing assistance in four U.S. cities: variations in local experienceAIDS Behav2007116 Suppl140-148. 46. Scott A, Ellen J, Clum G, Leonard L. HIV and housing assistance in four U.S. cities: variations in local experience. AIDS Behav 2007;11(6 Suppl):140–148.
47.
Waldrop-Valverde DValverde E. Homelessness and psychological distress as contributors to antiretroviral nonadherence in HIV-positive injecting drug usersAIDS Patient Care STDs200519326-334. 47. Waldrop-Valverde D, Valverde E. Homelessness and psychological distress as contributors to antiretroviral nonadherence in HIV-positive injecting drug users. AIDS Patient Care STDs 2005;19:326–334.
48.
Altice FLMezger JAHodges J et al. Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: Implications for program replicationClin Infect Dis200438Suppl 5S376-387. 48. Altice FL, Mezger JA, Hodges J, et al. Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: Implications for program replication. Clin Infect Dis 2004;38(Suppl 5):S376–387.
49.
McCance-Katz EFGourevitch MNArnsten JSarlo JRainey PJatlow P. Modified directly observed therapy (MDOT) for injection drug users with HIV diseaseAm J Addict200211271-278. 49. McCance-Katz EF, Gourevitch MN, Arnsten J, Sarlo J, Rainey P, Jatlow P. Modified directly observed therapy (MDOT) for injection drug users with HIV disease. Am J Addict 2002;11:271–278.
50.
Garland WHWohl ARValencia R et al. The acceptability of a directly-administered antiretroviral therapy (DAART) intervention among patients in public HIV clinics in Los Angeles, CaliforniaAIDS Care200719159-167. 50. Garland WH, Wohl AR, Valencia R, et al. The acceptability of a directly-administered antiretroviral therapy (DAART) intervention among patients in public HIV clinics in Los Angeles, California. AIDS Care 2007;19:159–167.
51.
Macalino GEHogan JWMitty JA et al. A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance usersAIDS2007211473-1477. 51. Macalino GE, Hogan JW, Mitty JA, et al. A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users. AIDS 2007;21:1473–1477.
52.
Maru DS-RBruce RDWalton M et al. Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapyAIDS Behav200812284-293. 52. Maru DS-R, Bruce RD, Walton M, et al. Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy. AIDS Behav 2008;12:284–293.
53.
Wolitski RJKidder DPPals SL et al. Randomized trial of the effects of housing assistance on the health and risk behaviors of homeless and unstably housed people living with HIVAIDS Behav201014493-503. 53. Wolitski RJ, Kidder DP, Pals SL, et al. Randomized trial of the effects of housing assistance on the health and risk behaviors of homeless and unstably housed people living with HIV. AIDS Behav 2010;14:493–503.
54.
Schwarcz SKHsu LCVittinghoff EVu ABamberger JDKatz MH. Impact of housing on the survival of persons with AIDSBMC Public Health20099220. 54. Schwarcz SK, Hsu LC, Vittinghoff E, Vu A, Bamberger JD, Katz MH. Impact of housing on the survival of persons with AIDS. BMC Public Health 2009;9:220.
55.
Attia SEgger MMuller MZwahlen MLow N. Sexual transmission of HIV according to viral load and antiretroviral therapy: Systematic review and meta-analysisAIDS2009231397-1404. 55. Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: Systematic review and meta-analysis. AIDS 2009;23:1397–1404.
56.
Montaner JSHogg RWood E et al. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemicLancet2006368531-536. 56. Montaner JS, Hogg R, Wood E, et al. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 2006;368:531–536.
57.
Wood EKerr TMarshall BD et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: Prospective cohort studyBMJ2009338b1649. 57. Wood E, Kerr T, Marshall BD, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: Prospective cohort study. BMJ 2009;338:b1649.
58.
Aidala ACross JEStall RHarre DSumartojo E. Housing status and HIV risk behaviors: Implications for prevention and policyAIDS Behav20059251-265. 58. Aidala A, Cross JE, Stall R, Harre D, Sumartojo E. Housing status and HIV risk behaviors: Implications for prevention and policy. AIDS Behav 2005;9:251–265.
59.
Chander GHimelhoch SMoore RD. Substance abuse and psychiatric disorders in HIV-positive patients: Epidemiology and impact on antiretroviral therapyDrugs200666769-789. 59. Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients: Epidemiology and impact on antiretroviral therapy. Drugs 2006;66:769–789.
Information & Authors
Information
Published In
Copyright
Copyright 2012, Mary Ann Liebert, Inc.
History
Published in print: January 2012
Published online: 20 December 2011
Published ahead of print: 22 November 2011
Topics
Authors
Author Disclosure Statement
No competing financial interests exist.
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Get Access
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.